Please enable JavaScript to continue using this application.

Compare $COAG vs $SNDX | Chartloom

Compare

$COAG vs $SNDX

Hemab Therapeutics Holdings Inc · Syndax Pharmaceuticals Inc

COAG

Hemab Therapeutics Holdings Inc

SNDX

Syndax Pharmaceuticals Inc

Compare $COAG vs $SNDX

Comparing Hemab Therapeutics Holdings Inc and Syndax Pharmaceuticals Inc

COAGHemab Therapeutics Holdings Inc

SNDXSyndax Pharmaceuticals Inc

COAGHemab Therapeutics Holdings Inc

Market cap

$1.48B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-7.0%

52W performance

-7.0%

FCF yield

0.0%

SNDXSyndax Pharmaceuticals Inc

Market cap

$1.51B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

222.7%

YTD performance

-20.2%

52W performance

3.0%

FCF yield

-14.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

COAG

SNDX

Detailed metrics comparison

COAG

Hemab Therapeutics Holdings Inc

SNDX

Syndax Pharmaceuticals Inc

Market Cap

COAG$1.48B

SNDX$1.51B

Enterprise Value

COAG$1.24B

SNDX$1.76B

Price

COAG$31.62

SNDX$16.99

P/E Ratio

COAGN/A

SNDXN/A

P/S Ratio

COAG0.00x

SNDX5.97x

EV/Sales

COAG0.00x

SNDX6.97x

EV/EBITDA

COAG0.00x

SNDX1,613.51x

P/B Ratio

COAG3.20x

SNDX104.09x

P/FCF Ratio

COAGN/A

SNDXN/A

EV/FCF

COAG0.00x

SNDX-7.96x

PEG Ratio

COAGN/A

SNDXN/A

Forward P/E (NTM)

COAGN/A

SNDXN/A

Forward P/S (NTM)

COAGN/A

SNDXN/A

Revenue (TTM)

COAG$0

SNDX$252M

Revenue Growth (YoY)

COAGN/A

SNDX222.7%

Forward Rev Growth

COAG1014.0%

SNDX41.0%

Gross Margin (TTM)

COAG0.0%

SNDX95.8%

Operating Margin (TTM)

COAG0.0%

SNDX0.0%

EBITDA Margin (TTM)

COAG0.0%

SNDX-77.0%

Net Margin (TTM)

COAG0.0%

SNDX-87.5%

FCF Margin (TTM)

COAGN/A

SNDX-87.6%

Net Income (TTM)

COAG$-47M

SNDX$-221M

FCF (TTM)

COAG$0

SNDX$-221M

EPS (TTM)

COAG-$1.00

SNDX-$2.48

ROE (TTM)

COAG0.0%

SNDX-37294.0%

ROA (TTM)

COAG0.0%

SNDX-3911.0%

ROIC (TTM)

COAG0.0%

SNDX-4756.0%

Cash

COAG$237M

SNDX$336M

Debt

COAG$0

SNDX$588M

Net Cash/Debt

COAG$237M

SNDX$-252M

Current Ratio (TTM)

COAG35.85x

SNDX6.77x

Quick Ratio (TTM)

COAG35.48x

SNDX6.32x

Debt/Equity (TTM)

COAG0.00x

SNDX38.95x

Debt/Assets (TTM)

COAG0.0%

SNDX0.0%

Interest Coverage (TTM)

COAGN/A

SNDXN/A

Net Debt/EBITDA (TTM)

COAG0.00x

SNDX0.00x

Beta

COAG-0.87

SNDX0.40

52W Performance

COAG-7.0%

SNDX3.0%

YTD Performance

COAG-7.0%

SNDX-20.2%

% from 52W High

COAG-42.9%

SNDX-33.6%

% from 52W Low

COAG37.5%

SNDX30.8%

Asset Turnover (TTM)

COAG0.00x

SNDX0.45x

FCF Yield (TTM)

COAG0.0%

SNDX-14.7%

Earnings Yield (TTM)

COAG-3.2%

SNDX-14.7%

Dividend Yield (TTM)

COAGN/A

SNDXN/A

Rule of 40

COAG0.0

SNDX135.1

EV/GP/RG

COAGN/A

SNDX0.15

Ticker research

View COAG research View SNDX research

Metric	COAG Hemab Therapeutics Holdings Inc	SNDX Syndax Pharmaceuticals Inc
Market & Valuation
Market Cap	$1.48B	$1.51B
Enterprise Value	$1.24B	$1.76B
Price	$31.62	$16.99
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	5.97x
EV/Sales	0.00x	6.97x
EV/EBITDA	0.00x	1,613.51x
P/B Ratio	3.20x	104.09x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-7.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$252M
Revenue Growth (YoY)	N/A	222.7%
Forward Rev Growth	1014.0%	41.0%
Profitability
Gross Margin (TTM)	0.0%	95.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-77.0%
Net Margin (TTM)	0.0%	-87.5%
FCF Margin (TTM)	N/A	-87.6%
Net Income (TTM)	$-47M	$-221M
FCF (TTM)	$0	$-221M
EPS (TTM)	-$1.00	-$2.48
ROE (TTM)	0.0%	-37294.0%
ROA (TTM)	0.0%	-3911.0%
ROIC (TTM)	0.0%	-4756.0%
Financial Health
Cash	$237M	$336M
Debt	$0	$588M
Net Cash/Debt	$237M	$-252M
Current Ratio (TTM)	35.85x	6.77x
Quick Ratio (TTM)	35.48x	6.32x
Debt/Equity (TTM)	0.00x	38.95x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.87	0.40
52W Performance	-7.0%	3.0%
YTD Performance	-7.0%	-20.2%
% from 52W High	-42.9%	-33.6%
% from 52W Low	37.5%	30.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.45x
FCF Yield (TTM)	0.0%	-14.7%
Earnings Yield (TTM)	-3.2%	-14.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	135.1
EV/GP/RG	N/A	0.15
Ticker research	View COAG research	View SNDX research

Valuation

P/S Ratio

COAG

0.00x

SNDX

5.97x

EV/FCF

SNDX

-7.96x

COAG

0.00x

Growth & revenue

Revenue Growth TTM

SNDX

222.7%

Forward Revenue Growth

COAG

1014.0%

SNDX

41.0%

Profitability & performance

Gross Margin

SNDX

95.8%

COAG

0.0%

ROE

COAG

0.0%

SNDX

-37294.0%

FCF Yield %

COAG

0.0%

SNDX

-14.7%

52-Week Performance

SNDX

3.0%

COAG

-7.0%

Detailed metrics comparison

COAG

Hemab Therapeutics Holdings Inc

SNDX

Syndax Pharmaceuticals Inc

Market Cap

COAG$1.48B

SNDX$1.51B

Enterprise Value

COAG$1.24B

SNDX$1.76B

Price

COAG$31.62

SNDX$16.99

P/E Ratio

COAGN/A

SNDXN/A

P/S Ratio

COAG0.00x

SNDX5.97x

EV/Sales

COAG0.00x

SNDX6.97x

EV/EBITDA

COAG0.00x

SNDX1,613.51x

P/B Ratio

COAG3.20x

SNDX104.09x

P/FCF Ratio

COAGN/A

SNDXN/A

EV/FCF

COAG0.00x

SNDX-7.96x

PEG Ratio

COAGN/A

SNDXN/A

Forward P/E (NTM)

COAGN/A

SNDXN/A

Forward P/S (NTM)

COAGN/A

SNDXN/A

Revenue (TTM)

COAG$0

SNDX$252M

Revenue Growth (YoY)

COAGN/A

SNDX222.7%

Forward Rev Growth

COAG1014.0%

SNDX41.0%

Gross Margin (TTM)

COAG0.0%

SNDX95.8%

Operating Margin (TTM)

COAG0.0%

SNDX0.0%

EBITDA Margin (TTM)

COAG0.0%

SNDX-77.0%

Net Margin (TTM)

COAG0.0%

SNDX-87.5%

FCF Margin (TTM)

COAGN/A

SNDX-87.6%

Net Income (TTM)

COAG$-47M

SNDX$-221M

FCF (TTM)

COAG$0

SNDX$-221M

EPS (TTM)

COAG-$1.00

SNDX-$2.48

ROE (TTM)

COAG0.0%

SNDX-37294.0%

ROA (TTM)

COAG0.0%

SNDX-3911.0%

ROIC (TTM)

COAG0.0%

SNDX-4756.0%

Cash

COAG$237M

SNDX$336M

Debt

COAG$0

SNDX$588M

Net Cash/Debt

COAG$237M

SNDX$-252M

Current Ratio (TTM)

COAG35.85x

SNDX6.77x

Quick Ratio (TTM)

COAG35.48x

SNDX6.32x

Debt/Equity (TTM)

COAG0.00x

SNDX38.95x

Debt/Assets (TTM)

COAG0.0%

SNDX0.0%

Interest Coverage (TTM)

COAGN/A

SNDXN/A

Net Debt/EBITDA (TTM)

COAG0.00x

SNDX0.00x

Beta

COAG-0.87

SNDX0.40

52W Performance

COAG-7.0%

SNDX3.0%

YTD Performance

COAG-7.0%

SNDX-20.2%

% from 52W High

COAG-42.9%

SNDX-33.6%

% from 52W Low

COAG37.5%

SNDX30.8%

Asset Turnover (TTM)

COAG0.00x

SNDX0.45x

FCF Yield (TTM)

COAG0.0%

SNDX-14.7%

Earnings Yield (TTM)

COAG-3.2%

SNDX-14.7%

Dividend Yield (TTM)

COAGN/A

SNDXN/A

Rule of 40

COAG0.0

SNDX135.1

EV/GP/RG

COAGN/A

SNDX0.15

Ticker research

View COAG research View SNDX research

Metric	COAG Hemab Therapeutics Holdings Inc	SNDX Syndax Pharmaceuticals Inc
Market & Valuation
Market Cap	$1.48B	$1.51B
Enterprise Value	$1.24B	$1.76B
Price	$31.62	$16.99
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	5.97x
EV/Sales	0.00x	6.97x
EV/EBITDA	0.00x	1,613.51x
P/B Ratio	3.20x	104.09x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-7.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$252M
Revenue Growth (YoY)	N/A	222.7%
Forward Rev Growth	1014.0%	41.0%
Profitability
Gross Margin (TTM)	0.0%	95.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-77.0%
Net Margin (TTM)	0.0%	-87.5%
FCF Margin (TTM)	N/A	-87.6%
Net Income (TTM)	$-47M	$-221M
FCF (TTM)	$0	$-221M
EPS (TTM)	-$1.00	-$2.48
ROE (TTM)	0.0%	-37294.0%
ROA (TTM)	0.0%	-3911.0%
ROIC (TTM)	0.0%	-4756.0%
Financial Health
Cash	$237M	$336M
Debt	$0	$588M
Net Cash/Debt	$237M	$-252M
Current Ratio (TTM)	35.85x	6.77x
Quick Ratio (TTM)	35.48x	6.32x
Debt/Equity (TTM)	0.00x	38.95x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.87	0.40
52W Performance	-7.0%	3.0%
YTD Performance	-7.0%	-20.2%
% from 52W High	-42.9%	-33.6%
% from 52W Low	37.5%	30.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.45x
FCF Yield (TTM)	0.0%	-14.7%
Earnings Yield (TTM)	-3.2%	-14.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	135.1
EV/GP/RG	N/A	0.15
Ticker research	View COAG research	View SNDX research